Fund HoldingsAtlas Venture Life Science Advisors, LLC

Total Portfolio Value
$521.76M
Total Bought
$132.07M
Total Sold
$44.36M
Net Transaction
+$87.71M
Filing Period:
Securities
SharesValue ($K)
Q4 2024
Q1 2025
Change
Q4 2024
Q1 2025
Weight (%)
Change
Sionna Therapeutics, Inc.(SION)03,694,020+3,694,020038,6397.41%+38,639
Vigil Neuroscience, Inc.5,836,8745,836,87409,92310,3901.99%+467
Spero Therapeutics, Inc.305,255305,25503142200.04%-95
Aerovate Therapeutics, Inc.1,799,2321,799,23204,7684,5160.87%-252
Ikena Oncology, Inc.5,018,1785,018,17808,2306,4231.23%-1,807
Tectonic Therapeutics, Inc.78,4470-78,4473,6220-3,622
Q32 Bio, Inc.2,092,1062,092,10607,1973,4520.66%-3,745
Generation Bio, Co.8,279,4848,279,48408,7763,3530.64%-5,423
Korro Bio, Inc.1,137,1491,137,149043,29119,7983.79%-23,493
Day One Biopharmaceuticals, Inc.
COM
6,430,2576,430,257081,47150,9929.77%-30,479
Disc Medicine, Inc.(IRON)2,509,4562,384,456-125,000159,100118,36422.69%-40,735
Kymera Therapeutics, Inc.(KYMR)4,896,4624,896,4620196,985134,01625.69%-62,969
Third Harmonic Bio, Inc.10,402,28610,402,2860107,04036,0966.92%-70,944
Dyne Therapeutics, Inc.(DYN)8,019,3549,130,465+1,111,111188,93695,50518.30%-93,431
Page 1 of 1